Revolution Medicines, Inc.
RVMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,837 | $6,922 | $6,653 | $7,337 |
| - Cash | $217 | $402 | $334 | $543 |
| + Debt | $158 | $133 | $134 | $136 |
| Enterprise Value | $8,778 | $6,652 | $6,454 | $6,930 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$206 | -$188 |
| % Margin | – | – | – | – |
| EBITDA | -$302 | -$261 | -$237 | -$213 |
| % Margin | – | – | – | – |
| Net Income | -$305 | -$248 | -$213 | -$195 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.61 | -1.31 | -1.13 | -1.13 |
| % Growth | -22.9% | -15.9% | 0% | – |
| Operating Cash Flow | -$207 | -$222 | -$194 | -$138 |
| Capital Expenditures | -$3 | -$7 | -$3 | -$1 |
| Free Cash Flow | -$211 | -$229 | -$198 | -$140 |